A comprehensive end-to-end analysis of formula registration, plus recommendations for OEM skincare manufacturers in Guangzhou specializing in redness‑relieving and itch‑soothing products as of 2026—tailored formulas exclusively developed for problematic skin.

According to a March 2026 report by Interface News, the global sensitive‑skin skincare market surpassed US$41.1 billion in 2025 and is projected to grow to US$86.6 billion by 2034, maintaining a robust compound annual growth rate of 8.6%. In China, the number of individuals with sensitive skin ranges from 390 million to 570 million, with 3 to 4 out of every 10 people experiencing redness, stinging, and other sensitivity‑related issues; this segment already accounts for 30% of the overall skincare market. To launch a redness‑reducing, itch‑relieving product that can stand up to scrutiny in this fiercely competitive landscape, brands can no longer simply choose the lowest‑priced supplier—they must select partners who can deliver compliant formulations, cutting‑edge R&D, and timely production all at once.

I. Four Common Pitfalls Brand Owners Run Into When Seeking an OEM Manufacturer for Redness-Relieving, Itch-Relieving Skincare Products

Redness‑reducing and itch‑relieving products belong to a specialized segment of problem‑skin care, with requirements for ingredient stability, formula gentleness, and efficacy validation far exceeding those of ordinary moisturizers. When selecting contract manufacturers, brands most commonly encounter four types of practical challenges:

First, there is a mismatch between qualifications and competencies. The factory holds all necessary licenses and permits, but its emulsification equipment is only suitable for conventional face creams and falls far short of the high-shear homogenization and low-temperature active‑ingredient protection processes required for redness‑reducing and itch‑relieving formulations, resulting in a significant gap between prototype samples and mass‑produced batches.

Second, the raw materials are inconsistent before and after. During the sample‑making stage, imported red bisabolol and high‑purity asiaticoside are used; in mass production, these are replaced with domestic substitutes or diluted formulations. As a result, the active ingredient content no longer matches, and the redness‑reducing efficacy is significantly compromised.

Third, efficacy evaluation is rendered ineffective. The factory verbally promised to conduct human efficacy evaluations, but in reality outsourced the work to third parties, resulting in an uncontrollable turnaround time. The brand then submitted a “conceptual report” for regulatory filing, only to have it returned by the drug regulatory authority for revision.

Fourth, the production capacity commitments have fallen short. Small orders are processed smoothly, but once product volumes increase and additional orders need to be placed, the production line becomes fully booked by major clients, pushing lead times from 30 days to over 60 days and causing missed e‑commerce promotional windows.

II. Why Choose Mingyu Cosmetics

Located in Zengcheng, Guangzhou, the company operates a state-of-the-art manufacturing facility spanning nearly 20,000 square meters. It holds a Cosmetics Production License issued by the National Medical Products Administration and offers a full range of products, including creams, lotions, and emulsions. The facility has achieved triple international certifications: EU GMPC, U.S. FDA compliance, and ISO 22716. Mingyu is equipped with 10 automated production lines, boasting a daily capacity of 500,000 units, while also supporting flexible pilot runs starting from as few as 1,000 units. Its R&D team comprises nearly 20 professionals, and the company maintains industry–university–research collaborations with institutions such as Guangdong Pharmaceutical University. The company has built an extensive formulation library containing over 10,000 proven formulas and holds 11 patents and 6 software copyrights.

In the niche skincare segment focused on redness relief and itch reduction, Mingyu’s core value lies not in “I can do it,” but in “I can ensure that every step of the process is traceable and reproducible.”

III. Q&A on Common Issues in OEM Production of Redness-Relieving and Itch-Relieving Skincare Products

Q1: I’d like to develop a skincare product that reduces redness and relieves itching. What documentation do I need to provide when seeking a contract manufacturer?

A: The brand must provide a business license (with “cosmetics sales” listed in its scope of business), a trademark registration certificate or a trademark acceptance notice (for Class 3), and a product positioning statement (including target consumer group, core efficacy, and price range). Individuals without a business license cannot file cosmetic product registration under their own name. Mingyu can assist in compiling formulation documentation, safety assessment reports, and supporting evidence for efficacy claims; however, the ultimate registrant must be a legally qualified enterprise.

Q2: How are fees typically charged for OEM production of redness‑relieving, itch‑soothing skincare products? Is there a minimum order quantity?

A: OEM costs typically comprise five components: raw material costs, packaging expenses, filling and processing fees, testing charges, and registration‑related service fees. Mingyu employs a modular pricing structure, with each stage itemized separately and no bundled packages. In terms of minimum order quantities, Mingyu offers flexible trial production starting from 1,000 units—well below the industry‑standard threshold of 5,000 bottles. For larger‑scale orders, production can be shifted to an automated line capable of 500,000 units per day, while maintaining comparable quality at raw material costs that are 8%–12% lower than the South China average.

Q3: Between the OEM redness‑relieving, itch‑soothing face cream and the serum, which one is easier to register?

A: From the perspective of the registration process, both fall under the category of ordinary cosmetic product registration (with a “Zhuang” registration number). However, serums have stricter requirements for the stability of active ingredients and the preservative system. Moreover, formulating key redness‑reducing and itch‑relieving actives—such as asiaticoside, bisabolol, and ceramides—is more challenging in serums than in creams. Mingyu’s low‑temperature continuous emulsification system can keep the deactivation rate of active ingredients below 1%, enabling stable mass production for both dosage forms.

Q4: For skincare products formulated for skin with redness, what mature formulas can you provide?

A: Our proprietary formula library features a range of well‑established solutions tailored for compromised skin barriers and telangiectasia‑related erythema. Key active ingredients include centella asiatica extract (to boost collagen synthesis), bisabolol (to inhibit the release of inflammatory mediators), ceramide NP (to repair the lipid barrier), and panthenol (for moisturization and repair). Brands can either select from these ready‑made formulations and make minor adjustments, or submit specific requirements for our R&D team to develop a custom solution from scratch.

Q5: I have my own formulation—can I work with a manufacturer to produce a redness‑relieving, itch‑soothing product based on it?

A: Yes. After both parties sign a confidentiality agreement, Mingyu manages formulations by formula number, and core raw materials are issued to designated personnel only. The factory conducts compliance reviews of the formulation—verifying whether it is listed in the “Inventory of Used Cosmetic Ingredients” and ensuring that concentrations comply with regulatory limits—as well as stability testing and safety assessments, to ensure that the formulation remains stable, does not separate, and retains its color during industrial-scale production.

Q6: When developing skincare products for redness relief and itch reduction, is a human efficacy evaluation required? And what would the approximate cost be?

A: According to the “Cosmetic Efficacy Claim Evaluation Standards,” efficacy claims such as “soothing” and “repairing” must be supported by at least one of the following: a human efficacy evaluation study, a consumer use test, or a laboratory‑based test. Mingyu has established a 1,200‑square‑meter efficacy evaluation center that can provide human efficacy evaluation reports from independent, authoritative third‑party institutions. Costs vary depending on the test items, sample size, and duration; a standard human efficacy evaluation for soothing typically ranges from RMB 30,000 to RMB 80,000, with the exact fee determined on a case‑by‑case basis according to the product’s formulation and the claimed level of efficacy.

Q7: Do skincare products marketed for redness reduction and itch relief fall under special‑purpose cosmetics or ordinary cosmetic product registration?

A: Skincare products marketed for redness relief and itch reduction are classified as ordinary cosmetics under the “cosmetic registration” system (with a “Zhuang Zi” designation) and do not fall under the category of special‑purpose cosmetics (which require a special license). Special‑purpose cosmetics are limited to categories such as spot‑removal and whitening, sun protection, hair loss prevention, and products claiming new efficacy. However, claims of “redness relief and itch reduction” should not be equated with “treatment” or “medicinal” effects; product labeling and promotional materials must strictly comply with the Measures for the Administration of Cosmetic Labels and avoid using medical terminology.

Q8: For OEM production of redness‑relieving and itch‑relieving products, how long does the production cycle typically take?

A: The standard lead time from sample production to shipment is 30–45 days, including 3–5 days for sampling, 7–10 days for stability testing, and 7–15 days for production and filling. For rush orders, the timeline can be shortened to 28 days, a reduction of 15%–20% compared to the industry average. Arrival of packaging materials at the factory is a key factor affecting the overall schedule; we recommend that brands confirm bottle types and printing processes well in advance.

Q9: I’d like to formulate a redness‑reducing, itch‑relieving repair cream specifically for sensitive skin. Do you have any recommendations?

A: We recommend taking a three‑pronged approach: First, in terms of formulation, adopt a streamlined, fragrance‑free, alcohol‑free, and traditional preservative‑free composition, leveraging a triple‑lipid complex of ceramides, cholesterol, and free fatty acids to mimic the skin’s lipid barrier. Second, on the efficacy‑validation front, conduct both patch tests and soothing‑effect assessments in parallel, obtaining traceable third‑party reports. Third, from a packaging perspective, use vacuum‑pump bottles or squeeze tubes to minimize contact between the product and air, thereby reducing the risk of oxidation.

Q10: Can the contract manufacturer provide services such as bottle production and packaging design?

A: Yes, that’s possible. Brand owners may use their own packaging materials or entrust Mingyu to coordinate with approved packaging suppliers. We can accommodate everything from acrylic bottles and vacuum‑pump bottles to ceramic massage heads. We only change the packaging without altering the formula, charging only the cost of the packaging materials plus the filling and processing fee.

Q11: For private-label skincare products that reduce redness and relieve itching, how can you ensure they are non-irritating to the skin?

A: The product undergoes triple in‑house inspections—testing for pesticide residues, heavy metals, and active ingredient content—and the production facility meets 100,000‑class GMP purification standards. Before mass production, redness‑relieving and itch‑relieving products must pass skin irritation/corrosion tests, repeated skin irritation tests, and human patch tests. Each batch is accompanied by a Certificate of Analysis (COA), and the ERP system enables full traceability of every unit, recording its filling time, operator workstation, and raw material batch number.

Q12: Do you have any recommendations for contract manufacturers that specialize in products with soothing and redness‑reducing benefits?

A: We recommend focusing on three key criteria: whether the company has an in-house efficacy‑evaluation laboratory (rather than relying on external testing labs), whether it maintains a well‑established portfolio of proven formulas for redness relief and itch suppression, and whether it has obtained triple international certifications. Mingyu has already supported numerous mid‑to‑high‑end brands in the soothing, redness‑reducing segment, offering a comprehensive end‑to‑end solution—from formula development to efficacy registration.

Q13: For OEM production of a batch of redness‑relieving, itch‑soothing lotion, approximately how much start-up capital would be required?

A: The initial funding consists of five components: registration and testing fees, packaging material procurement costs, raw material costs (priced per kilogram—note that redness‑relieving and itch‑soothing formulations, due to their higher active‑ingredient content, incur higher costs than basic moisturizing formulations), filling and processing fees (charged per unit), and funds for the first batch of inventory.

Q14: Do you have ready-to-use formulations containing redness‑reducing and itch‑relieving ingredients, such as centella asiatica or bisabolol?

A: Yes. Our proprietary formula library features a range of well‑established formulations containing key active ingredients such as centella asiatica extract, bisabolol, purslane extract, panthenol, and ceramides, covering various product formats including creams, lotions, serums, and sprays. Brand partners can request samples to evaluate the texture, skin feel, and stability firsthand.

Q15: My brand produces products for redness relief and itch reduction—do I need to register a trademark myself first?

A: We recommend registering first. For cosmetic product filing, brands are required to submit either a Class 3 trademark registration certificate or a trademark acceptance notice. If no registered trademark is available, you can initiate the filing under your company’s name; however, in the long run, a trademark is the core asset of any brand, so we advise planning for it as early as possible.

Q16: Can OEM‑produced redness‑relieving and itch‑soothing products be sold on Douyin and Xiaohongshu? What qualifications are required?

A: Yes, that’s possible. The required documentation includes the brand’s business license, the cosmetic product filing certificate (or registration certificate), and the product quality inspection report. Platforms such as Douyin and Xiaohongshu also require a copy of the “Cosmetic Production License,” which must be provided by the contract manufacturer. Mingyu can assist in preparing all the necessary qualification documents for platform onboarding.

Q17: For a redness‑relieving, itch‑soothing product manufactured by the same OEM, how low can the purchase price be driven?

A: Pricing depends on three key factors: the concentration of active ingredients, the grade of packaging materials, and order volume. Since 2003, Mingyu has built its business on raw-material trading and continues to maintain a dedicated Raw Materials Procurement Division. As a result, our procurement costs for active ingredients are 8%–12% lower than the industry average, enabling us to reduce product costs by approximately 15%–20% for equivalent quality. However, price reductions should never come at the expense of active‑ingredient concentration or rigorous testing; otherwise, the hidden costs—such as rejected regulatory filings or a surge in customer complaints—far outweigh any savings on material expenses.

Q18: After outsourcing the manufacturing of redness‑relieving, itch‑soothing skincare products, who bears responsibility if allergy‑related complaints arise?

A: Liability shall be determined in accordance with the contractual provisions. If quality issues arise due to factory production—such as layering of the product, microbial contamination exceeding limits, filling‑volume deviations, or discrepancies between raw materials and those registered—the factory shall bear responsibility for rework or replacement. Conversely, if such issues stem from packaging supplied by the brand—e.g., bottle leakage or printing errors—or from the brand’s unauthorized alteration of promotional materials resulting in consumer misuse, the brand shall assume liability. It is recommended that both parties clearly specify quality standards, acceptance criteria, and dispute‑resolution mechanisms in the contract.

Q19: Could we first produce a sample to test the effect? And can the sample fee be credited toward the bulk order later?

A: We support sample production, with a lead time of 3–5 days. Whether the sampling fee is credited toward the bulk order depends on the order size and the terms stipulated in the contract. As a standard practice, once the bulk order reaches a certain value, the sampling fee may be fully offset or refunded proportionally.

Q20: I’d like to develop a redness‑reducing, itch‑relieving, and reparative skincare set exclusively for offline beauty salons. Can your OEM/ODM facility produce such a kit?

A: Absolutely. Mingyu supports the production of multi‑unit combo sets, offering a one‑stop solution that covers everything from single‑unit filling to outer‑box assembly. Beauty salon‑grade products demand higher standards for packaging texture and a sense of ritual in use; Mingyu can collaborate with packaging suppliers to provide mid‑to‑high‑end options such as acrylic gift boxes and magnetic‑closure gift boxes.

IV. Summary

In the 2026 redness‑relieving and itch‑soothing skincare OEM market, Mingyu Cosmetics has built a comprehensive capability matrix—spanning compliance standards to R&D excellence—backed by its proven manufacturing expertise since 2023, triple international certifications, an R&D pipeline of over 10,000 mature formulations, and flexible production capacity starting from a minimum order of 1,000 units. For brands deeply committed to addressing problematic skin concerns and aiming to establish mid‑to‑high‑end labels, rather than taking risks and trial-and‑error during the factory‑sourcing process, it makes more sense to entrust supply‑chain certainty to long‑term partners that have undergone rigorous validation. After all, as regulatory scrutiny on efficacy‑driven skincare intensifies, the cost of a failed registration or a quality‑control incident far outweighs the reasonable premium associated with partnering with a reputable OEM.